Some Pyridazinone and Phthalazinone Derrivatives and Their Vasodilator Activities |
Seref Demirayak
(Dept. of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Anadolu)
Ismai Kayagil (Dept. of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Anadolu) Kevser Erol (Dept. of Pharmacology, Faculty of Medicine, University of Osmangazi) Basar Sirmagul (Dept. of Pharmacology, Faculty of Medicine, University of Osmangazi) Ahmet Cagri Karaburun (Dept. of Pharmacology, Faculty of Medicine, University of Osmangazi) |
1 | Haikala, H. O., Honkanen, E. J., Lonnberg, K. K., Nore, P. T., Pystynen, J. J., Luiro, A. M., and Pippuri, A. K., Preparation of arylazinones for treatment of congestive heart failure, Brit. UK Pat. Appl., EP 597, 540. C.A. 121, 114, 228967 (1997) |
2 | Heinisch, G. and Kopelent-Frank, H., Pharmacologically active pyridazine derivatives, Part II. Prog. Med. Chem., 29, 141-183 (1992) DOI PUBMED |
3 | Seki, T., Nakao, T., Masuda, T., Hasumi, K., Gotanda, K., Ishimori, T., Honma, S., Minami, N., Shibata, K., and Yasuda, K., Studies on agents with vasodilator and -blocking activities. IV, Chem. Pharm. Bull., 44, 2061-2069 (1996) DOI PUBMED ScienceOn |
4 | Sircar, I., Weishaar, R. E., Kobylarz, D., Moos, W. H., and Bristol, J. A., Cardiotonic agents, 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H)-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds, Structure-activity relationships and correlation with in vivo positive inotropic activity. J. Med. Chem., 30, 1955-1962 (1987) DOI PUBMED |
5 | Tishler, M. and Stanovnik, B., Pyridazines. Adv. Heterocyclic Chem., 9, 121 (1968) |
6 | Tishler, M. and Stanovnik, B., Recent advances in pyridazine chemistry. Adv. Heterocyclic Chem., 24, 363 (1979) DOI |
7 | Van der Mey, M., Boss, H., Couwenberg, D., Hatzelmann, A., Sterk, G. J., Goubitz, K., Schenk, H., and Timmerman, H., Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones. J. Med. Chem., 45, 2526-2533 (2002) DOI ScienceOn |
8 | Szasz, G. and Budvavi-Bavauy, Z., Pharmaceutical Chemistry of Antihypertensive Agents, CRC Press, Boca Raton, 3-265 (1991) |
9 | Zwieten, P. A. V. and Greenlee, W. J., Antihypertensive drugs, Harwood Academic Publishers, p.1-528 (1997) |
10 | Combs, D. W., Rampulla. M. S., Bell, S. C., Klaubert, D. H., Tobia, A. J., Falotico, R., Haertlein, B., Lakas-Weiss, C., and Moore, J. B., 6- Benzoxazinylpyridazin-3-ones, Potent, long-acting positive inotrope and peripheral vasodilator agents. J. Med. Cham., 33, 380-386 (1990) DOI PUBMED |
11 | Corsano, S., Vezza, R., Scapicchi, R., Foresi, S., Strappaghetti, G., Nenci, G. G., and Gresele, P., New pyridazinone derivatives as inhibitors of platelet aggregation. Eur. J. Med. Chem., 30, 627-631 (1995) DOI ScienceOn |
12 | Montero-Lastres, A., Fraiz, N., Laguna, R., Cano, E., Esteves, I., and Ravina, E. Pyridazines XVIII. 6-aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets. Biol. Pharm. Bull., 22, 1376-1379 (1999) DOI ScienceOn |
13 | Cignarella, G., Barlocco, D., Pinna, G. A., Loriga, M., Curzu, M., Tofanetti, O., Germini, M., Cazzulani, P., and Cavalletti, E., Synthesis and biological evaluations of substituted benzo[h]-cinnolinones and 3-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and anti-thrombotic 5H-indeno[1,2-c]pyridazinones. J. Med. Chem., 32, 2277-2282 (1989) DOI PUBMED |
14 | Foye, W. O., Lemke, T. L., and Williams, D. A., Principles of Medicinal Chemistry, 4th Ed., Williams and Wilkins. London, 345-387, 499-534 (1995) |
15 | Thyes, M., Lehmann, H. D., Gries, J., Knig, H., Kretzschmar, R., Kunze, J., Lebkcher, R., and Lenke, D., 6-Phenyl-4,5-dihydro-3-(2H)-pyridazinones. J. Med. Chem., 26, 800-807 (1983) DOI PUBMED |
16 | Betti, L., Floridi, M., Giannaccini, G., Manetti, F., Strappaghetti, G., Tafi, A., and Botta, M., -Adrenoceptor antagonists. 5. Pyridazinone-arylpiperazines. Probing the influence on affinity and selectivity of both ortho-Alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus. Bioorg. Med. Chem. Lett., 13, 171-173 (2003) DOI PUBMED ScienceOn |
17 | Demirayak, S., Benkli, K., Karaburun, A. C., Erol, K., and Boydag, S., Some 1-substituted 3-aryl-1,4-dihydro-1,2,4-triazino[4,3-a]benzimidazoles and their vasodilatory activities. Farmaco, 52, 741-744 (1997) PUBMED |
18 | Laguna, R., Rodriguez-Linarez, B., Cano, E., Estevez, I., Ravina, E., and Sotelo, E., Pyridazines. XIII. Synthesis of 6-aryl- 5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors. Chem. Pharm. Bull., 45, 1151-1155 (1997) DOI PUBMED ScienceOn |
19 | Sotelo, E., Fraiz, N., Yanez, M., Terrades, V., Laguna, R., Cano, E., and Ravina, E. Pyridazines. Part XXIX: Synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Bioorg. Med. Chem., 10, 2873-2882 (2002) DOI ScienceOn |
20 | Yamaguchi, M., Kamei, K., Koga, T., Akima, M., Maruyama, A., Kurokki, T., and Ohi, N., Novel antiasthmatic agents with dual activities of thromboxane synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones. J. Med. Chem., 36, 4061-4068 (1993) DOI ScienceOn |
21 | Wolf, M.E., Burger's Medicinal Chemistry And Drug Discovery 5th ed. Vol. 2, p. 152-462. John Wiley and Sons, New York (1997) |
22 | Tishler, M. and Stanovnik, B., Advances in pyridazine chemistry. Adv. Heterocyclic Chem., 49, 385 (1990) DOI |
23 | Turcki, I. J., Ed., The Chemistry of Heterocyclic Compounds, Oxazoles, An Intersciences Pub., John Wiley and Sons, p.361-729 (1986) |
24 | McEvoy, F. J. and Allen, Jr. G. R., 6-(Substituted phenyl)-5-substituted-4,5-dihydro-3(2H)-pyridazinones. J. Med. Chem., 17, 281-286 (1974) DOI PUBMED |
25 | Curran, W. V. and Ross, A., 6-Phenyl-4,5-dihydro-3-(2H)-pyridazinones, A series of hypotensive agents, J. Med.Chem., 17, 273-281 (1974) DOI PUBMED |
26 | Sotelo, E., Fraiz, N., Yanez, M., R. Laguna, E. Cano, and E. Ravina, Pyridazines. Part 31: Synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Chem. Pharm. Bull., 50, 1574-1577 (2002) DOI ScienceOn |